Source: Eur Respir J 2010; 35: 700-701



Rating:

Share or cite this content

Citations should be made in the following way:
Tsangaris I, Orfanos S, Bouros D.. Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification. Eur Respir J 2010; 35: 700-701

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension: diagnosis and classification Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach Year: 2009 Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics Source: Eur Respir J 2005; 25: 783-788 Year: 2005 Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey Source: International Congress 2014 – Clinical presentations Year: 2014 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management Source: Eur Respir J, 53 (1) 1801916; 10.1183/13993003.01916-2018 Year: 2019 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Pulmonary hypertension: pathophysiology and diagnosis Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007 Different definitions of pulmonary hypertension in interstitial lung disease: a prognostic evaluation. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 The French registry of pulmonary arterial hypertension in children: characteristics at diagnosis Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care Source: Eur Respir J 2008; 32: 945-952 Year: 2008 Pulmonary hypertension: a paradigm for rare pulmonary diseases Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017 Year: 2017 Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021 Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis Source: Eur Respir J, 54 (2) 1900586; 10.1183/13993003.00586-2019 Year: 2019 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Eur Respir J 2016; 47: 45-68 Year: 2016 Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management Source: Guideline 2016 Year: 2016